An active metabolite of metamizole
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

4-Methylaminoantipyrine (hydrochloride)

Item No. 31612

Technical Information
Formal Name
1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one, monohydrochloride
CAS Number
856307-27-2
Synonyms
  • Metamizole Impurity C
Molecular Formula
C12H15N3O • HCl
Formula Weight
Purity
≥95%
A solid
Water: Soluble
SMILES
O=C1N(C2=CC=CC=C2)N(C)C(C)=C1NC.Cl
InChi Code
InChI=1S/C12H15N3O.ClH/c1-9-11(13-2)12(16)15(14(9)3)10-7-5-4-6-8-10;/h4-8,13H,1-3H3;1H
InChi Key
NNONRTWOIVTAHL-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    4-Methylaminoantipyrine is a major active metabolite of the non-opioid prodrug metamizole (Item No. 15771).1 It is formed from metamizole by non-enzymatic hydrolysis in the gastrointestinal tract.2 4-Methylaminoantipyrine (0.1 mM) inhibits production of prostaglandin E2 (PGE2; Item No. 14010) induced by the calcium ionophore A23187 (Item Nos. 11016 | 22030) in isolated mouse peritoneal macrophages.3 It increases the paw withdrawal threshold in a rat model of carrageenan-induced hyperalgesia when administered at a dose of 160 µg/paw.4 4-Methylaminoantipyrine (60, 90, and 120 mg/kg) reduces LPS-induced pyrexia in rats.5 It is also a potential impurity found in commercial preparations of metamizole.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rogosch, T., Sinning, C., Podlewski, A., et alNovel bioactive metabolites of dipyrone (metamizol). Bioorg. Med. Chem. 20(1), 101-107 (2012).

    2. Nikolova, I., Tencheva, J., Voynikov, Y., et alMetamizole: A review profile of a well-known “forgotten” drug. Part I: Pharmaceutical and nonclinical profile. Biotechnol. Biotechnol. Equip. 26(6), 3329-3337 (2012).

    3. Brune, K., Aehringhaus, U., and Peskar, B.A. Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages. Agents Actions 14(5-6), 729-734 (1984).

    4. Gonçalves Dos Santos, G., Vieira, W.F., Vendramini, P.H., et alDipyrone is locally hydrolyzed to 4-methylaminoantipyrine and its antihyperalgesic effect depends on CB2 and κ-opioid receptors activation. Eur. J. Pharmacol. 874, 173005 (2020).

    5. Malvar, D.d.C., Aguiar, F.A., Vaz Ade, L., et alDipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2 -dependent and -independent fever while 4-AA only blocks PGE2 -dependent fever. Br. J. Pharmacol. 171(15), 3666-3679 (2014).

    6. Vieira, J.C., Sversut, R.A., Maciel, I.T., et alHPLC–DAD method for simultaneous determination of dipyrone (metamizole) and caffeine in tablets and identification of major degradation product by direct infusion ESI–MS. Chromatographia 80(3), 489–495 (2017).